Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
24.75 (1y: +22%)
Market Cap 415.8 M P/E(ttm) 31.40
Enterprise Value 270.4 M P/B 2.10
CYNO- NAS (USA)
Cynosure, Inc.
  • Currently 1/5
Business Predictability Rank: 1-Star
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$24.75
Switch to:

GuruFocus Financial Strength Rank measures how strong a companyย’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry		 vs
history
Cash to Debt 168.003
CYNO's Cash to Debt is ranked higher than
52% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3750.67 vs. CYNO: 168.003 )
CYNO' s 10-Year Cash to Debt Range
Min: 0.93   Max: 501.94
Current: 168
0.93
501.94
Equity to Asset 0.749
CYNO's Equity to Asset is ranked higher than
67% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 0.53 vs. CYNO: 0.749 )
CYNO' s 10-Year Equity to Asset Range
Min: 0.4   Max: 0.85
Current: 0.75
0.4
0.85
Interest Coverage No Debt
CYNO's Interest Coverage is ranked higher than
64% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 420.30 vs. CYNO: No Debt )
CYNO' s 10-Year Interest Coverage Range
Min: 10   Max: No Debt
Current: No Debt
F-Score: 8
Z-Score: 8.12
M-Score: -2.24
GuruFocus Profitability Rank ranks how profitable a company is and how likely the companyย’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ย•ย•3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry		 vs
history
Operating margin (%) 7.90
CYNO's Operating margin (%) is ranked higher than
65% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 5.80 vs. CYNO: 7.90 )
CYNO' s 10-Year Operating margin (%) Range
Min: -27.9   Max: 15.7
Current: 7.9
-27.9
15.7
Net-margin (%) 7.1
CYNO's Net-margin (%) is ranked higher than
75% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.25 vs. CYNO: 7.1 )
CYNO' s 10-Year Net-margin (%) Range
Min: -31.3   Max: 12.7
Current: 7.1
-31.3
12.7
ROE (%) 5.5
CYNO's ROE (%) is ranked higher than
71% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 4.80 vs. CYNO: 5.5 )
CYNO' s 10-Year ROE (%) Range
Min: -78.3   Max: 36.2
Current: 5.5
-78.3
36.2
ROA (%) 4.7
CYNO's ROA (%) is ranked higher than
77% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.40 vs. CYNO: 4.7 )
CYNO' s 10-Year ROA (%) Range
Min: -41.3   Max: 18.9
Current: 4.7
-41.3
18.9
ROC (Joel Greenblatt) (%) 38.80
CYNO's ROC (Joel Greenblatt) (%) is ranked higher than
87% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 14.00 vs. CYNO: 38.80 )
CYNO' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -66   Max: 55.5
Current: 38.8
-66
55.5
Revenue Growth (%) 18.1
CYNO's Revenue Growth (%) is ranked higher than
56% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. CYNO: 18.1 )
CYNO' s 10-Year Revenue Growth (%) Range
Min: -9.9   Max: 18.1
Current: 18.1
-9.9
18.1
ยป CYNO's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

CYNO Guru Trades in Q2 2012

Mario Gabelli 24,000 sh (unchged)
Chuck Royce Sold Out
Jim Simons 10,900 sh (-43.23%)
» More
Q3 2012

CYNO Guru Trades in Q3 2012

Steven Cohen 14,934 sh (New)
Jim Simons 48,300 sh (+343.12%)
Mario Gabelli 24,000 sh (unchged)
» More
Q4 2012

CYNO Guru Trades in Q4 2012

Joel Greenblatt 18,472 sh (New)
Steven Cohen 18,154 sh (+21.56%)
Jim Simons 54,400 sh (+12.63%)
Mario Gabelli 24,000 sh (unchged)
» More
Q1 2013

CYNO Guru Trades in Q1 2013

Paul Tudor Jones 18,100 sh (New)
Jim Simons 120,219 sh (+120.99%)
Joel Greenblatt Sold Out
Mario Gabelli 20,000 sh (-16.67%)
Steven Cohen 9,275 sh (-48.91%)
» More
» Details

Insider Trades

Latest Guru Trades with CYNO

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-03-31 Sold Out 0.03%$24.11 - $29.85 $ 23.98-11%0
Joel Greenblatt 2012-12-31 New Buy0.03%$21.2 - $27.48 $ 23.98-2%18472
Charles Brandes 2012-03-31 Sold Out 0.01%$12 - $19.28 $ 23.9867%0
Charles Brandes 2011-03-31 Add 106.12%0.01%$10.23 - $14.43 $ 23.9897%79678
Mario Gabelli 2011-03-31 Reduce -75.31%$10.23 - $14.43 $ 23.9897%24000
Charles Brandes 2010-12-31 Add 46.03%$9.48 - $10.98 $ 23.98131%38657
Mario Gabelli 2010-09-30 Add 247.14%$9.04 - $10.45 $ 23.98146%97200
Mario Gabelli 2010-06-30 Reduce -71.86%$10.6 - $13.6 $ 23.98100%28000
Premium More recent guru trades are included for Premium Members only!!

Ratios

vs
industry		 vs
history
P/E(ttm) 31.70
CYNO's P/E(ttm) is ranked higher than
55% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 24.10 vs. CYNO: 31.70 )
CYNO' s 10-Year P/E(ttm) Range
Min: 5.38   Max: 630.2
Current: 31.7
5.38
630.2
P/B 2.10
CYNO's P/B is ranked lower than
56% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.99 vs. CYNO: 2.10 )
CYNO' s 10-Year P/B Range
Min: 0.46   Max: 5.12
Current: 2.1
0.46
5.12
P/S 2.30
CYNO's P/S is ranked lower than
61% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. CYNO: 2.30 )
CYNO' s 10-Year P/S Range
Min: 0.5   Max: 4.75
Current: 2.3
0.5
4.75
PFCF 42.20
CYNO's PFCF is ranked higher than
53% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 18.60 vs. CYNO: 42.20 )
CYNO' s 10-Year PFCF Range
Min: 8.7   Max: 164.91
Current: 42.2
8.7
164.91
EV-to-EBIT 21.3
CYNO's EV-to-EBIT is ranked higher than
52% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 16.25 vs. CYNO: 21.3 )
CYNO' s 10-Year EV-to-EBIT Range
Min: 1.1   Max: 311.7
Current: 21.3
1.1
311.7
Shiller P/E 1040.9
CYNO's Shiller P/E is ranked higher than
75% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 23.60 vs. CYNO: 1040.9 )
CYNO' s 10-Year Shiller P/E Range
Min: 565.25   Max: 1492.5
Current: 1040.9
565.25
1492.5

Valuation & Return

vs
industry		 vs
history
Price/Net Cash 4.3
CYNO's Price/Net Cash is ranked higher than
87% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 12.00 vs. CYNO: 4.3 )
CYNO' s 10-Year Price/Net Cash Range
Min: 2   Max: 5.9
Current: 4.3
2
5.9
Price/Net Current Asset Value 10.6
CYNO's Price/Net Current Asset Value is ranked higher than
76% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 8.90 vs. CYNO: 10.6 )
CYNO' s 10-Year Price/Net Current Asset Value Range
Min: 3.1   Max: 9.9
Current: 10.6
3.1
9.9
Price/Tangible Book 2.2
CYNO's Price/Tangible Book is ranked higher than
63% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.80 vs. CYNO: 2.2 )
CYNO' s 10-Year Price/Tangible Book Range
Min: 0.8   Max: 2.8
Current: 2.2
0.8
2.8
Price/DCF (Projected) 1.9
CYNO's Price/DCF (Projected) is ranked higher than
94% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.25 vs. CYNO: 1.9 )
CYNO' s 10-Year Price/DCF (Projected) Range
Min: 1.1   Max: 1.6
Current: 1.9
1.1
1.6
Price/Median PS Value 1.3
CYNO's Price/Median PS Value is ranked higher than
88% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 0.80 vs. CYNO: 1.3 )
CYNO' s 10-Year Price/Median PS Value Range
Min: 0.4   Max: 1.4
Current: 1.3
0.4
1.4
Price/Graham Number 1.9
CYNO's Price/Graham Number is ranked higher than
79% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 1.80 vs. CYNO: 1.9 )
CYNO' s 10-Year Price/Graham Number Range
Min: 0.7   Max: 1.8
Current: 1.9
0.7
1.8
Earnings Yield (Greenblatt) 4.70
CYNO's Earnings Yield (Greenblatt) is ranked higher than
70% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 5.95 vs. CYNO: 4.70 )
CYNO' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.3   Max: 94.8
Current: 4.7
0.3
94.8
Forward Rate of Return (Yacktman) 1.81
CYNO's Forward Rate of Return (Yacktman) is ranked higher than
70% of the 165 Companies
in the Global Medical Devices industry.

( Industry Median: 3.03 vs. CYNO: 1.81 )
CYNO' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 1.4   Max: 2.5
Current: 1.81
1.4
2.5

Business Description

Cynosure, Inc. was incorporated under the laws of the State of Delaware in July 1991. The Company develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair rejuvenate the skin through the treatment of vascular and pigmented lesions, remove multi-colored tattoos, liquefy and remove unwanted fat through laser lypolysis, reduce cellulite and treat onychomycosis. It is also developing in conjunction with its development agreement with Unilever Ltd., (Unilever) a laser treatment system for the home use market. Its systems incorporate a broad range of laser and other light-based energy sources, including Alexandrite, pulse dye, Nd:Yag and diode lasers, as well as intense pulsed light. It offers single energy source systems as well as workstations that incorporate two or more different types of lasers or pulsed light technologies. It offers multiple technologies and system alternatives at a variety of price points depending mainly on the number and type of energy sources included in the system. Its newer products are designed to be easily upgradeable to add additional energy sources and handpieces, which provide its customers with technological flexibility as they expand their practices. It sell its products through a direct sales force in North America, France, Spain, the United Kingdom, Germany, Korea, China, Japan and Mexico and through international distributors in 97 other countries. Its products competes against laser and other light-based products offered by public companies, such as Syneron Medical Ltd., Cutera, Inc., Palomar Medical Technologies, Inc. and Solta Medical, Inc. The Company's products are medical devices subject to extensive and rigorous regulation by the U.S. Food and Drug Administration, or FDA, as well as other regulatory bodies.
Company Website
SEC Reports
Industry: Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ
Traded in other countries:C9S.Germany
ยป More Articles for CYNO

Headlines

Articles On GuruFocus.com
Cynosure Inc. (CYNO) CFO Timothy W Baker buys 2,500 Shares Feb 27 2009 
Cynosure Inc. (CYNO) CEO Michael R Davin buys 2,500 Shares Feb 27 2009 
Stocks Trading Below Net Cash: Adaptec Inc (ADPT), AuthenTec Inc (AUTH) and Cutera Inc (CUTR). Feb 16 2009 
Cynosure: A Value Play on Vanity Jan 18 2009 

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial